Post-Learning
Expert Q&A – Asthma Management: Applying Phenotyping and Endotyping to Improve Outcomes in Uncontrolled Asthma
Release Date: December 10, 2021
Expiration Date: December 9, 2022
Not certified for credit.
Begin »
Program Overview
Program Description
During PCE's recent Pulmonary Bootcamp, attendees had the chance to ask our expert faculty a variety of questions about severe and uncontrolled asthma. Here, Ann Hefel, MS, FNP-BC, RN, instructor in the Department of Pediatric Allergy and Immunology at the University of Colorado School of Medicine, and Mark Liu, MD, associate professor of Medicine in the Division of Pulmonology and Critical Care Medicine at Johns Hopkins University, provide their responses to the questions asked during the live presentation. We hope you will find their responses relevant to your practice.
In Partnership With the Association of Pulmonary Advanced Practice Providers
Faculty
Ann Hefel, FNP-BC, MS, RN
- Instructor
- Department of Pediatrics, Allergy & Immunology
- University of Colorado
- Aurora, Colorado
Mark Liu, MD
- Associate Professor of Medicine
- Division of Pulmonology and Critical Care Medicine
- Johns Hopkins University
- Baltimore, Maryland
Details
This program is cosupported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; Genentech, a member of the Roche Group; GlaxoSmithKline; Jazz Pharmaceuticals, Inc.; and Mylan Specialty L.P.
This activity is supported by educational grants from Genentech, a member of the Roche Group; and GlaxoSmithKline.
Ms Hefel has no relevant financial relationships to disclose.
Dr Liu: consulting fees: AstraZeneca; contracted research/consulting fees: GlaxoSmithKline, Gossamer Bio.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 103121PBC-Q4